Article Versions Notes

Lefebvre M, Duchatelet M, El Hajj H, De Courrèges A, Wallet J, Bellier C, Le Tinier F, Le Deley MC, Martinez Gomez C, Leblanc E, et al. Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current Oncology. 2023; 30(1):1174-1185. https://doi.org/10.3390/curroncol30010090

Lefebvre, Manon, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie Cécile Le Deley, Carlos Martinez Gomez, Eric Leblanc, and et al. 2023. "Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?" Current Oncology 30, no. 1: 1174-1185. https://doi.org/10.3390/curroncol30010090

Lefebvre, M., Duchatelet, M., El Hajj, H., De Courrèges, A., Wallet, J., Bellier, C., Le Tinier, F., Le Deley, M. C., Martinez Gomez, C., Leblanc, E., Narducci, F., & Hudry, D. (2023). Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current Oncology, 30(1), 1174-1185. https://doi.org/10.3390/curroncol30010090